PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
1660485-0	1991	Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.	Asp-Gly-Arg	110-121	fibroblast growth factor 2	Homo sapiens	49-79
1660485-0	1991	Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.	Asp-Gly-Arg	110-121	fibroblast growth factor 2	Homo sapiens	81-85
1660485-0	1991	Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.	Asp-Gly-Arg	110-121	fibroblast growth factor 2	Homo sapiens	179-183
20708923-1	2010	BACKGROUND: NGR-hTNF consists of human tumour necrosis factor (hTNF) fused with the tumour-homing peptide Asp-Gly-Arg (NGR), which is able to selectively bind an aminopeptidase N overexpressed on tumour blood vessels.	Asp-Gly-Arg	106-117	reticulon 4 receptor	Homo sapiens	12-15
20708923-1	2010	BACKGROUND: NGR-hTNF consists of human tumour necrosis factor (hTNF) fused with the tumour-homing peptide Asp-Gly-Arg (NGR), which is able to selectively bind an aminopeptidase N overexpressed on tumour blood vessels.	Asp-Gly-Arg	106-117	tumor necrosis factor	Homo sapiens	16-20
20708923-1	2010	BACKGROUND: NGR-hTNF consists of human tumour necrosis factor (hTNF) fused with the tumour-homing peptide Asp-Gly-Arg (NGR), which is able to selectively bind an aminopeptidase N overexpressed on tumour blood vessels.	Asp-Gly-Arg	106-117	tumor necrosis factor	Homo sapiens	63-67
20708923-1	2010	BACKGROUND: NGR-hTNF consists of human tumour necrosis factor (hTNF) fused with the tumour-homing peptide Asp-Gly-Arg (NGR), which is able to selectively bind an aminopeptidase N overexpressed on tumour blood vessels.	Asp-Gly-Arg	106-117	reticulon 4 receptor	Homo sapiens	119-122
29414325-3	2018	One differentiating factor of interferon-beta (IFN-beta) from other type I interferons is the presence of theAsn-Gly-Arg (NGR) sequence motif, which, upon deamidation, converts to Asp-Gly-Arg (DGR) and iso-Asp-Gly-Arg (iso-DGR) motifs.	Asp-Gly-Arg	180-191	interferon beta 1	Homo sapiens	30-45
29414325-3	2018	One differentiating factor of interferon-beta (IFN-beta) from other type I interferons is the presence of theAsn-Gly-Arg (NGR) sequence motif, which, upon deamidation, converts to Asp-Gly-Arg (DGR) and iso-Asp-Gly-Arg (iso-DGR) motifs.	Asp-Gly-Arg	180-191	interferon beta 1	Homo sapiens	47-55